Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Whither Sanofi? How Easily Can the Drug Maker Find a New CEO?
WSJ Pharmalot
Wednesday, October 29, 2014 - 11:50am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher
MannKind: What To Expect From Earnings
Seeking Alpha
Wednesday, October 29, 2014 - 11:24am
tags:
MannKind, earnings
AbbVie Expected To Post Mixed Q3 Results
Bidness Etc.
Wednesday, October 29, 2014 - 10:16am
tags:
AbbVie, earnings
U.S. law firm says investigating AbbVie over collapsed Shire deal
Yahoo/Reuters
Wednesday, October 29, 2014 - 10:13am
tags:
AbbVie, Shire, M&A
Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations
TheStreet.com
Wednesday, October 29, 2014 - 9:38am
tags:
Aegerion, Pharma CEOs, Marc Beer
Positive Results For Cara Therapeutics Pain Drug (CR845) In Human Abuse Liability Trial
Forbes
Wednesday, October 29, 2014 - 9:35am
tags:
Cara Therapeutics, painkillers, CR845
Dr. Reddy’s Q2 and H1 FY15 Financial Results
Yahoo
Wednesday, October 29, 2014 - 9:34am
tags:
Dr Reddy's, earnings
Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake
Forbes
Wednesday, October 29, 2014 - 9:18am
tags:
Sanofi, Chris Viehbacher
Arena Skimps on Data Disclosure From Weight-Loss Combo Study
TheStreet.com
Wednesday, October 29, 2014 - 9:16am
tags:
Arena Pharmaceuticals, Belviq, Bel-phen
New Tax Rules Won’t Stop Pfizer From Bidding U.S. Goodbye
Bloomberg
Wednesday, October 29, 2014 - 9:14am
tags:
Pfizer, tax inversions, M&A
Lilly, Boehringer revise terms of diabetes drugs alliance
Yahoo/Reuters
Wednesday, October 29, 2014 - 9:08am
tags:
diabetes, Eli Lilly, Boehringer Ingelheim
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
Yahoo
Wednesday, October 29, 2014 - 9:00am
tags:
JNJ, Asia, innovation
In Ebola Crisis, New Vaccine Candidates Show Uncertain Promise
Forbes
Wednesday, October 29, 2014 - 8:59am
tags:
ebola virus, vaccines, Novavax, GSK, JNJ
Sanofi CEO Christopher Viehbacher Fired Over Solitary Management Style, Chairman Says
WSJ Online
Wednesday, October 29, 2014 - 7:58am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher
Orphan drug pricing for non-orphan meds? Express Scripts is looking at you, Gilead
Fierce Pharma Marketing
Tuesday, October 28, 2014 - 6:59pm
tags:
drug pricing, Express Scripts, Gilead Sciences, Harvoni, Sovaldi
BDSI Developing Long-Acting Vaccine for Pain Treatment
Drug Discovery and Development
Tuesday, October 28, 2014 - 6:57pm
tags:
BioDelivery Sciences, vaccines, buprenorphine, painkillers
Ackman-Allergan Enters Courtroom Phase: Opening Line
Bloomberg
Tuesday, October 28, 2014 - 6:51pm
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Gilead third-quarter Sovaldi sales dip, but net profit triples
Yahoo/Reuters
Tuesday, October 28, 2014 - 6:49pm
tags:
Gilead Sciences, earnings
Sanofi Diabetes Outlook Signals an ‘Undisciplined’ Price War may Erupt
WSJ Pharmalot
Tuesday, October 28, 2014 - 1:57pm
tags:
Sanofi, diabetes, Eli Lilly
[video]Amgen CEO: We're not splitting up
CNBC
Tuesday, October 28, 2014 - 11:35am
tags:
Amgen, restructuring, Bob Bradway

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.